Annual Long Term Debt
$5.34 M
-$568.40 K-9.63%
30 September 2022
Summary:
NeuBase Therapeutics annual long term debt is currently $5.34 million, with the most recent change of -$568.40 thousand (-9.63%) on 30 September 2022. During the last 3 years, it has fallen by -$568.40 thousand (-9.63%).NBSE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$4.83 M
-$129.70 K-2.61%
30 September 2023
Summary:
NeuBase Therapeutics quarterly long term debt is currently $4.83 million, with the most recent change of -$129.70 thousand (-2.61%) on 30 September 2023.NBSE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -9.6% | -16.1% |
| 5 y5 years | - | - |
NBSE Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -9.6% | -18.1% |
NeuBase Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $4.83 M(-2.6%) |
| June 2023 | - | $4.96 M(-2.5%) |
| Mar 2023 | - | $5.09 M(-2.4%) |
| Dec 2022 | - | $5.21 M(-2.3%) |
| Sept 2022 | $5.34 M(-9.6%) | $5.34 M(-2.7%) |
| June 2022 | - | $5.48 M(-3.1%) |
| Mar 2022 | - | $5.66 M(-1.8%) |
| Dec 2021 | - | $5.76 M(-2.4%) |
| Sept 2021 | $5.90 M(>+9900.0%) | $5.90 M(+0.0%) |
| June 2021 | - | $5.90 M(>+9900.0%) |
| Sept 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2018 | $250.00 K | $250.00 K(+412.3%) |
| June 2010 | - | $48.80 K(-17.0%) |
| Mar 2010 | - | $58.80 K(+5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | - | $55.80 K(-80.1%) |
| Sept 2009 | $280.00 K(+1117.4%) | $280.00 K(+20.7%) |
| June 2009 | - | $232.00 K(-21.4%) |
| Mar 2009 | - | $295.00 K(+1367.7%) |
| Mar 2006 | - | $20.10 K(-12.6%) |
| Dec 2005 | $23.00 K(-28.8%) | $23.00 K(-33.7%) |
| Sept 2005 | - | $34.70 K(+30.9%) |
| June 2005 | - | $26.50 K(-32.7%) |
| Mar 2005 | - | $39.40 K(+22.0%) |
| Dec 2004 | $32.30 K(+152.3%) | $32.30 K(-5.6%) |
| Sept 2004 | - | $34.20 K(+210.9%) |
| June 2004 | - | $11.00 K(-9.8%) |
| Mar 2004 | - | $12.20 K |
| Dec 2003 | $12.80 K | - |
FAQ
- What is NeuBase Therapeutics annual long term debt?
- What is the all time high annual long term debt for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for NeuBase Therapeutics?
What is NeuBase Therapeutics annual long term debt?
The current annual long term debt of NBSE is $5.34 M
What is the all time high annual long term debt for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual long term debt is $5.90 M
What is NeuBase Therapeutics quarterly long term debt?
The current quarterly long term debt of NBSE is $4.83 M
What is the all time high quarterly long term debt for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly long term debt is $5.90 M